What Is Donor Eligibility? (21 CFR 1271 Subpart C) — Requirements Explained

Donor Eligibility Requirements — 21 CFR 1271 Subpart C

What is donor eligibility?
Donor eligibility refers to the regulatory process used to determine whether a tissue donor meets screening and testing requirements to reduce the risk of communicable disease transmission.

In simple terms, donors must be evaluated through medical screening and laboratory testing before tissue can be used.

Donor eligibility determination is a regulatory safeguard established under 21 CFR 1271 Subpart C to reduce the risk of communicable disease transmission associated with Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).

These requirements operate within the broader regulatory framework defined under 21 CFR Part 1271.

Donor eligibility is one component of the overall regulatory evaluation applied to HCT/Ps, alongside criteria such as minimal manipulation, homologous use, and manufacturing safeguards.

For a structured overview of all regulatory components, see the Regulatory Resource Library.

Documentation and Regulatory Education

Not sure how these requirements apply to your current sourcing or protocols?

Licensed medical professionals and organizations may request educational materials related to donor eligibility requirements, screening standards, and regulatory safeguards referenced within this resource.

Credential verification may be required prior to documentation access.

Request Information

Provider Credential Verification Portal

Schedule a Professional Consultation

Donor eligibility determination under 21 CFR 1271 Subpart C including screening testing and traceability
Educational reference illustrating donor eligibility determination requirements under 21 CFR Part 1271 Subpart C.

Donor Screening — 21 CFR 1271.75

  • Medical history evaluation
  • Behavioral risk factor assessment
  • Communicable disease exposure review

Donor Testing — 21 CFR 1271.80

Donor testing must be performed using appropriately qualified laboratories and validated testing methodologies for communicable disease markers.


Eligibility Determination — 21 CFR 1271.45

A responsible person must make a formal donor eligibility determination based on screening and testing results in accordance with regulatory criteria.


Role in Regulatory Classification


Additional traceability and documentation safeguards are addressed in Donor Screening, Traceability, and Quality Standards .


Related Regulatory Topics

This information is for educational purposes only.

Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.

For use by licensed medical professionals.